Polynovo Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,942.00
1,414.30
3,251.80
5,006.00
5,974.10
Depreciation, Depletion & Amortization
215.20
205.20
219.70
247.00
542.90
Other Funds
-
-
2,544.20
-
-
Funds from Operations
2,240.90
2,573.00
2,624.30
4,266.10
5,757.90
Changes in Working Capital
188.80
133.10
742.40
686.50
1,083.30
Net Operating Cash Flow
2,429.70
2,439.90
3,366.70
4,952.60
6,841.20
Capital Expenditures
76.30
317.40
204.70
581.70
220.00
Sale of Fixed Assets & Businesses
-
41.40
-
-
-
Purchase/Sale of Investments
-
1,510.00
83.90
-
19,000.00
Net Investing Cash Flow
1,023.70
1,234.00
120.80
581.70
19,220.00
Net Financing Cash Flow
3,288.70
-
10,765.40
376.70
23,644.10
Net Change in Cash
1,882.70
1,205.90
7,286.20
5,250.10
2,349.50
Free Cash Flow
2,506.00
2,757.30
3,571.40
5,534.30
7,061.20
Other Sources
1,100.00
-
-
-
-
Change in Capital Stock
3,288.70
-
13,309.60
376.70
23,644.10
Exchange Rate Effect
-
-
8.30
92.40
67.50

About Polynovo

View Profile
Address
320 Lorimer Street
Port Melbourne Victoria (VIC) 3207
Australia
Employees -
Website http://polynovo.com.au
Updated 07/08/2019
Polynovo Ltd. operates as a biotechnology company. It designs, develops and manufactures solutions for standalone and combination devices using its NovoSorb biodegradable polymer technology. The company's products are NovoPore is used as a dressing in negative pressure wound therapy and Biodegradable Temporising Matrix is a wound dressing intended for treatment of full-thickness wounds.